MMIT (Managed Markets Insight & Technology, LLC) is regarded as a trusted go-to-market partner that helps pharmaceutical manufacturers understand how patients move from diagnosis to treatment while eliminating barriers to care.
What started as a division of Medi-Media—an agency supporting pharmaceutical clients in key areas of commercialization—more than two decades ago, MMIT went on to acquire other industry-leading life sciences solutions providers, including Atlantic Information Services (AIS), Zitter Health Insights and RJ Health.
Today, MMIT helps pharma companies see the full patient journey using our data assets, expertise and insights—providing a valuable understanding of the market that helps you identify patients who need your therapy the most while avoiding barriers to access.
Looking for a glimpse into the current and future patient access landscape? MMIT’s annual survey, The State of Patient Access, sheds light on what’s keeping pharma leaders up at night—and what gets them going in the morning. Take a look at the full findings—and our expert analysis—in the 2024 State of Patient Access research report.
